Use of lipid-lowering drugs in older adults with and without dementia: A community-based epidemiological study

Eric G. Rodriguez, Hiroko Dodge, Maria A. Birzescu, Gary P. Stoehr, Mary Ganguli

Research output: Contribution to journalArticle

85 Citations (Scopus)

Abstract

OBJECTIVES: To compare the use of lipid-loweringdrugs in community-dwelling older adults with and without dementia. DESIGN: Comparison of lipid-lowering drug use by demented cases and nondemented controls based on secondary analysis of data from a longitudinal epidemiologic study. SETTING: Longitudinal study of a largely rural, low-ocioeconomic community-based cohort of older persons residing in the mid-Monongahela Valley of Southest Pennsylvania (the Monongahela Valley Independent Elders Survey). PARTICIPANTS: Eight hundred forty-five individuals of mean ± standard deviation (SD) age of 80.5 ± 4.6, participating in the fifth biennial wave of data collection. MEASUREMENTS: Demographics; medical history; medication regimen (including examination of prescription bottle labels); self-report of most recent visit to primary care physician (PCP); and standardized clinical assessment to determine presence of dementia, including Clinical Dementia Rating (CDR). RESULTS: One hundred seventy participants (20.1% of total subject cohort) had dementia, with a CDR of 0.5 or greater. Mean ages of demented and nondemented individuals were 83.5 ± 5.1 and 79.8 ± 4.2, respectively. Similar proportions, 87.7% and 89.5%, of these groups reported PCP visits in the previous year. Of the total sample, 9.4% (3.5% of the demented and 10.8% of the nondemented) were taking lipid-lowering drugs. After adjustment for age, sex, education, visit with PCP within the past year, and potential confounding clinical and lifestyle variables (self-reported heart disease, stroke or transient ischemic attacks, hypertension, smoking, and alcohol consumption), dementia was associated with a lower likelihood of taking a lipid-lowering drug (odds ratio = 0.39, 95% confidence interval = 0.16 16-0.95). In post hoc subgroup analyes, similar results were found when restricting lipid-low-ring drugs to statins alone but were not statistically significant. Drug use was not associated with severity of dementia (CDR = 0.5 vs CDR ≥ 1). CONCLUSIONS: Demented individuals were less likely than their nondemented counterparts to be taking lipid-lowering drugs. This finding could reflect different prescribing patterns by physicians for demented and nondemented patients or a possible protective effect of these drugs against dementia.

Original languageEnglish (US)
Pages (from-to)1852-1856
Number of pages5
JournalJournal of the American Geriatrics Society
Volume50
Issue number11
DOIs
StatePublished - Nov 1 2002
Externally publishedYes

Fingerprint

Dementia
Epidemiologic Studies
Lipids
Pharmaceutical Preparations
Primary Care Physicians
Longitudinal Studies
Physicians' Practice Patterns
Independent Living
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Protective Agents
Sex Education
Transient Ischemic Attack
Alcohol Drinking
Self Report
Prescriptions
Life Style
Heart Diseases
Smoking
Stroke
Odds Ratio

Keywords

  • Alzheimer's disease
  • Antilipemic drugs
  • Older people
  • Statins

ASJC Scopus subject areas

  • Geriatrics and Gerontology

Cite this

Use of lipid-lowering drugs in older adults with and without dementia : A community-based epidemiological study. / Rodriguez, Eric G.; Dodge, Hiroko; Birzescu, Maria A.; Stoehr, Gary P.; Ganguli, Mary.

In: Journal of the American Geriatrics Society, Vol. 50, No. 11, 01.11.2002, p. 1852-1856.

Research output: Contribution to journalArticle

Rodriguez, Eric G. ; Dodge, Hiroko ; Birzescu, Maria A. ; Stoehr, Gary P. ; Ganguli, Mary. / Use of lipid-lowering drugs in older adults with and without dementia : A community-based epidemiological study. In: Journal of the American Geriatrics Society. 2002 ; Vol. 50, No. 11. pp. 1852-1856.
@article{bb71c54418a941389532f1ccdb0f43e7,
title = "Use of lipid-lowering drugs in older adults with and without dementia: A community-based epidemiological study",
abstract = "OBJECTIVES: To compare the use of lipid-loweringdrugs in community-dwelling older adults with and without dementia. DESIGN: Comparison of lipid-lowering drug use by demented cases and nondemented controls based on secondary analysis of data from a longitudinal epidemiologic study. SETTING: Longitudinal study of a largely rural, low-ocioeconomic community-based cohort of older persons residing in the mid-Monongahela Valley of Southest Pennsylvania (the Monongahela Valley Independent Elders Survey). PARTICIPANTS: Eight hundred forty-five individuals of mean ± standard deviation (SD) age of 80.5 ± 4.6, participating in the fifth biennial wave of data collection. MEASUREMENTS: Demographics; medical history; medication regimen (including examination of prescription bottle labels); self-report of most recent visit to primary care physician (PCP); and standardized clinical assessment to determine presence of dementia, including Clinical Dementia Rating (CDR). RESULTS: One hundred seventy participants (20.1{\%} of total subject cohort) had dementia, with a CDR of 0.5 or greater. Mean ages of demented and nondemented individuals were 83.5 ± 5.1 and 79.8 ± 4.2, respectively. Similar proportions, 87.7{\%} and 89.5{\%}, of these groups reported PCP visits in the previous year. Of the total sample, 9.4{\%} (3.5{\%} of the demented and 10.8{\%} of the nondemented) were taking lipid-lowering drugs. After adjustment for age, sex, education, visit with PCP within the past year, and potential confounding clinical and lifestyle variables (self-reported heart disease, stroke or transient ischemic attacks, hypertension, smoking, and alcohol consumption), dementia was associated with a lower likelihood of taking a lipid-lowering drug (odds ratio = 0.39, 95{\%} confidence interval = 0.16 16-0.95). In post hoc subgroup analyes, similar results were found when restricting lipid-low-ring drugs to statins alone but were not statistically significant. Drug use was not associated with severity of dementia (CDR = 0.5 vs CDR ≥ 1). CONCLUSIONS: Demented individuals were less likely than their nondemented counterparts to be taking lipid-lowering drugs. This finding could reflect different prescribing patterns by physicians for demented and nondemented patients or a possible protective effect of these drugs against dementia.",
keywords = "Alzheimer's disease, Antilipemic drugs, Older people, Statins",
author = "Rodriguez, {Eric G.} and Hiroko Dodge and Birzescu, {Maria A.} and Stoehr, {Gary P.} and Mary Ganguli",
year = "2002",
month = "11",
day = "1",
doi = "10.1046/j.1532-5415.2002.50515.x",
language = "English (US)",
volume = "50",
pages = "1852--1856",
journal = "Journal of the American Geriatrics Society",
issn = "0002-8614",
publisher = "Wiley-Blackwell",
number = "11",

}

TY - JOUR

T1 - Use of lipid-lowering drugs in older adults with and without dementia

T2 - A community-based epidemiological study

AU - Rodriguez, Eric G.

AU - Dodge, Hiroko

AU - Birzescu, Maria A.

AU - Stoehr, Gary P.

AU - Ganguli, Mary

PY - 2002/11/1

Y1 - 2002/11/1

N2 - OBJECTIVES: To compare the use of lipid-loweringdrugs in community-dwelling older adults with and without dementia. DESIGN: Comparison of lipid-lowering drug use by demented cases and nondemented controls based on secondary analysis of data from a longitudinal epidemiologic study. SETTING: Longitudinal study of a largely rural, low-ocioeconomic community-based cohort of older persons residing in the mid-Monongahela Valley of Southest Pennsylvania (the Monongahela Valley Independent Elders Survey). PARTICIPANTS: Eight hundred forty-five individuals of mean ± standard deviation (SD) age of 80.5 ± 4.6, participating in the fifth biennial wave of data collection. MEASUREMENTS: Demographics; medical history; medication regimen (including examination of prescription bottle labels); self-report of most recent visit to primary care physician (PCP); and standardized clinical assessment to determine presence of dementia, including Clinical Dementia Rating (CDR). RESULTS: One hundred seventy participants (20.1% of total subject cohort) had dementia, with a CDR of 0.5 or greater. Mean ages of demented and nondemented individuals were 83.5 ± 5.1 and 79.8 ± 4.2, respectively. Similar proportions, 87.7% and 89.5%, of these groups reported PCP visits in the previous year. Of the total sample, 9.4% (3.5% of the demented and 10.8% of the nondemented) were taking lipid-lowering drugs. After adjustment for age, sex, education, visit with PCP within the past year, and potential confounding clinical and lifestyle variables (self-reported heart disease, stroke or transient ischemic attacks, hypertension, smoking, and alcohol consumption), dementia was associated with a lower likelihood of taking a lipid-lowering drug (odds ratio = 0.39, 95% confidence interval = 0.16 16-0.95). In post hoc subgroup analyes, similar results were found when restricting lipid-low-ring drugs to statins alone but were not statistically significant. Drug use was not associated with severity of dementia (CDR = 0.5 vs CDR ≥ 1). CONCLUSIONS: Demented individuals were less likely than their nondemented counterparts to be taking lipid-lowering drugs. This finding could reflect different prescribing patterns by physicians for demented and nondemented patients or a possible protective effect of these drugs against dementia.

AB - OBJECTIVES: To compare the use of lipid-loweringdrugs in community-dwelling older adults with and without dementia. DESIGN: Comparison of lipid-lowering drug use by demented cases and nondemented controls based on secondary analysis of data from a longitudinal epidemiologic study. SETTING: Longitudinal study of a largely rural, low-ocioeconomic community-based cohort of older persons residing in the mid-Monongahela Valley of Southest Pennsylvania (the Monongahela Valley Independent Elders Survey). PARTICIPANTS: Eight hundred forty-five individuals of mean ± standard deviation (SD) age of 80.5 ± 4.6, participating in the fifth biennial wave of data collection. MEASUREMENTS: Demographics; medical history; medication regimen (including examination of prescription bottle labels); self-report of most recent visit to primary care physician (PCP); and standardized clinical assessment to determine presence of dementia, including Clinical Dementia Rating (CDR). RESULTS: One hundred seventy participants (20.1% of total subject cohort) had dementia, with a CDR of 0.5 or greater. Mean ages of demented and nondemented individuals were 83.5 ± 5.1 and 79.8 ± 4.2, respectively. Similar proportions, 87.7% and 89.5%, of these groups reported PCP visits in the previous year. Of the total sample, 9.4% (3.5% of the demented and 10.8% of the nondemented) were taking lipid-lowering drugs. After adjustment for age, sex, education, visit with PCP within the past year, and potential confounding clinical and lifestyle variables (self-reported heart disease, stroke or transient ischemic attacks, hypertension, smoking, and alcohol consumption), dementia was associated with a lower likelihood of taking a lipid-lowering drug (odds ratio = 0.39, 95% confidence interval = 0.16 16-0.95). In post hoc subgroup analyes, similar results were found when restricting lipid-low-ring drugs to statins alone but were not statistically significant. Drug use was not associated with severity of dementia (CDR = 0.5 vs CDR ≥ 1). CONCLUSIONS: Demented individuals were less likely than their nondemented counterparts to be taking lipid-lowering drugs. This finding could reflect different prescribing patterns by physicians for demented and nondemented patients or a possible protective effect of these drugs against dementia.

KW - Alzheimer's disease

KW - Antilipemic drugs

KW - Older people

KW - Statins

UR - http://www.scopus.com/inward/record.url?scp=0036842773&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036842773&partnerID=8YFLogxK

U2 - 10.1046/j.1532-5415.2002.50515.x

DO - 10.1046/j.1532-5415.2002.50515.x

M3 - Article

C2 - 12410906

AN - SCOPUS:0036842773

VL - 50

SP - 1852

EP - 1856

JO - Journal of the American Geriatrics Society

JF - Journal of the American Geriatrics Society

SN - 0002-8614

IS - 11

ER -